Cargando…
Lipid and Inflammatory Cardiovascular Risk Worsens Over 3 Years in Youth With Type 2 Diabetes: The TODAY clinical trial
OBJECTIVE: Type 2 diabetes increases cardiovascular risk. We examined lipid profiles and inflammatory markers in 699 youth with recent-onset type 2 diabetes in the TODAY clinical trial and compared changes across treatment groups: metformin alone (M), metformin plus rosiglitazone (M+R), and metformi...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661790/ https://www.ncbi.nlm.nih.gov/pubmed/23704675 http://dx.doi.org/10.2337/dc12-2388 |
Ejemplares similares
-
Retinopathy in Youth With Type 2 Diabetes Participating in the TODAY Clinical Trial
Publicado: (2013) -
Monogenic Diabetes in Overweight and Obese Youth Diagnosed with Type
2 Diabetes: The TODAY Clinical Trial
por: Kleinberger, Jeffrey W., et al.
Publicado: (2017) -
Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes: The TODAY clinical trial
Publicado: (2013) -
Pregnancy Outcomes in Youth With Type 2 Diabetes: The TODAY Study Experience
por: Klingensmith, Georgeanna J., et al.
Publicado: (2016) -
Safety and Tolerability of the Treatment of Youth-Onset Type 2 Diabetes: The TODAY experience
Publicado: (2013)